Harnessing type I interferon-mediated immunity to target malignant brain tumors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing type I interferon-mediated immunity to target malignant brain tumors
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-05-25
DOI
10.3389/fimmu.2023.1203929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients
- (2023) Natalia Lehman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Single-cell spatial immune landscapes of primary and metastatic brain tumours
- (2023) Elham Karimi et al. NATURE
- Breaking down the cellular responses to type I interferon neurotoxicity in the brain
- (2023) Barney Viengkhou et al. Frontiers in Immunology
- Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas
- (2023) Chengcheng Guo et al. JAMA Network Open
- Transcriptome analysis reveals tumor microenvironment changes in glioblastoma
- (2023) Youri Hoogstrate et al. CANCER CELL
- Immune Functions of Astrocytes in Viral Neuroinfections
- (2023) Jernej Jorgačevski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10
- (2022) Vidhya M. Ravi et al. Nature Communications
- Type I interferon-mediated tumor immunity and its role in immunotherapy
- (2022) Renren Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
- (2022) Alan T. Yeo et al. NATURE IMMUNOLOGY
- Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells
- (2022) Tomokazu S. Sumida et al. NATURE IMMUNOLOGY
- Interferon‑α and its effects on cancer cell apoptosis (Review)
- (2022) Weiye Shi et al. Oncology Letters
- Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
- (2022) Barbara Breznik et al. Communications Biology
- Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
- (2022) Karl John Habashy et al. BRITISH JOURNAL OF CANCER
- Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy
- (2022) Catalina Lee-Chang NEURO-ONCOLOGY
- Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
- (2022) Filippo Birocchi et al. Science Translational Medicine
- Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
- (2022) Minjie Wang et al. Cell Death & Disease
- Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery
- (2022) Tala Shekarian et al. Science Advances
- Recent and future perspectives on engineering interferons and other cytokines as therapeutics
- (2022) Theint Aung et al. TRENDS IN BIOCHEMICAL SCIENCES
- Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
- (2022) Rachael M. Zemek et al. Nature Communications
- Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma
- (2022) Hyun-Jin Kim et al. Nature Communications
- Transcriptome Analysis Identifies Accumulation of Natural Killer Cells with Enhanced Lymphotoxin-β Expression during Glioblastoma Progression
- (2022) Gianni Monaco et al. Cancers
- Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models
- (2022) Evelina Blomberg et al. Translational Oncology
- Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy
- (2022) Weixin Chen et al. Cell Reports
- Cancer cell-derived type I interferons instruct tumor monocyte polarization
- (2022) Dylan Kwart et al. Cell Reports
- The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
- (2022) Jay A. Bowman-Kirigin et al. Cancer Immunology Research
- Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
- (2022) Jing Zhou et al. Cancer Medicine
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
- (2022) Linda M. Liau et al. JAMA Oncology
- Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors
- (2022) Saad M Khan et al. Journal for ImmunoTherapy of Cancer
- The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
- (2021) Asieh Emami Nejad et al. Cancer Cell International
- Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
- (2021) Michelle von Locquenghien et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads
- (2021) Natacha Zanin et al. Frontiers in Immunology
- Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
- (2021) Natalia Ochocka et al. Nature Communications
- Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
- (2021) Amélie Cachot et al. Science Advances
- Type I and II Interferons in the Anti-Tumor Immune Response
- (2021) Sarah E. Fenton et al. Cancers
- The Role of Microglia in Glioblastoma
- (2021) Noelia Geribaldi-Doldán et al. Frontiers in Oncology
- Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
- (2021) Zohreh Amoozgar et al. Nature Communications
- Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
- (2021) Marika Lanza et al. Brain Sciences
- Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
- (2021) Rikke Sick Andersen et al. Cancers
- The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation
- (2021) Martina Musella et al. Biology-Basel
- Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
- (2021) Ellen Duong et al. IMMUNITY
- Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
- (2021) Jiao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
- (2021) Angeliki Datsi et al. Frontiers in Immunology
- Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
- (2021) Sabbir Khan et al. Cancers
- Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma
- (2021) Ileana S. Mauldin et al. Cells
- Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma
- (2021) Cong He et al. Frontiers in Cell and Developmental Biology
- Combining radiotherapy with interferons; back to the future
- (2020) R.S.A. Goedegebuure et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Interferon‑β sensitizes human glioblastoma cells to the cyclin‑dependent kinase inhibitor, TG02
- (2020) Birthe Lohmann et al. Oncology Letters
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex–mediated STAT1 downregulation
- (2020) Xiaoyan Zhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I Interferon Receptor Signaling in Astrocytes Regulates Hippocampal Synaptic Plasticity and Cognitive Function of the Healthy CNS
- (2020) Shirin Hosseini et al. Cell Reports
- Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
- (2020) Wanzun Lin et al. Frontiers in Oncology
- Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma
- (2020) Hao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer
- (2020) Alexander James Sedgwick et al. Frontiers in Immunology
- Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
- (2020) Hans Raskov et al. BRITISH JOURNAL OF CANCER
- Revisiting the PD-1 pathway
- (2020) Nikolaos Patsoukis et al. Science Advances
- Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy
- (2020) Hongsheng Wang et al. CANCER LETTERS
- Engineering cytokines and cytokine circuits
- (2020) Aileen W. Li et al. SCIENCE
- Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
- (2020) Na Zhang et al. Frontiers in Immunology
- Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes
- (2020) Lisa Nieland et al. TRENDS IN NEUROSCIENCES
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
- (2019) Siddhartha Srivastava et al. Cancers
- Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma
- (2019) Dieter Henrik Heiland et al. Nature Communications
- Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
- (2019) Eda K. Holl et al. Frontiers in Immunology
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- Interferon target-gene expression and epigenomic signatures in health and disease
- (2019) Franck J. Barrat et al. NATURE IMMUNOLOGY
- Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4+ T Cells
- (2019) Assaf Magen et al. Cell Reports
- Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNA
- (2018) Tamara Tyrinova et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Astrocytes, the rising stars of the glioblastoma microenvironment
- (2018) Mayra Brandao et al. GLIA
- Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression
- (2018) Aya Hirata et al. CANCER GENE THERAPY
- Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
- (2018) Yong Liang et al. Nature Communications
- Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
- (2017) Kun Chen et al. JOURNAL OF AUTOIMMUNITY
- Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
- (2017) Dwijit GuhaSarkar et al. Molecular Oncology
- Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
- (2017) Ruan F.V. Medrano et al. Oncotarget
- Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression
- (2017) Jing Liao et al. Cancer Immunology Research
- Type I Interferons and Natural Killer Cell Regulation in Cancer
- (2017) Lena Müller et al. Frontiers in Immunology
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
- (2016) Tobias Goldmann et al. CURRENT OPINION IN NEUROBIOLOGY
- Cytotoxic CD4+ T cells are correlated with better prognosis in Han Chinese grade II and grade III glioma subjects and are suppressed by PD-1 signaling
- (2016) Jing Ge et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma
- (2016) Magdalena Kijewska et al. Oncotarget
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
- (2015) Mahua Dey et al. JOURNAL OF IMMUNOLOGY
- Type I IFN gene delivery suppresses regulatory T cells within tumors
- (2014) H Hashimoto et al. CANCER GENE THERAPY
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
- (2014) Haifeng C. Xu et al. IMMUNITY
- Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
- (2014) Josh Crouse et al. IMMUNITY
- Interferon- Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
- (2014) C. Happold et al. MOLECULAR CANCER THERAPEUTICS
- Aging-induced type I interferon response at the choroid plexus negatively affects brain function
- (2014) K. Baruch et al. SCIENCE
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
- (2013) William A Flavahan et al. NATURE NEUROSCIENCE
- Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
- (2013) Giovanna Schiavoni et al. Frontiers in Immunology
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- Role of Type 1 IFNs in Antiglioma Immunosurveillance--Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
- (2010) M. Fujita et al. CLINICAL CANCER RESEARCH
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started